Genotype-Phenotype Association of Matrix Metalloproteinase-3 Polymorphism and Its Synergistic Effect With Smoking on the Occurrence of Acute Coronary Syndrome

Ping-Yen Liu, Yi-Heng Li, Shih-Hung Chan, Li Jen Lin, Hua-Lin Wu, Guey Yueh Shi, Jyh Hong Chen

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Matrix metalloproteinase-3 (MMP-3) degrades the extracellular matrix and may contribute to the weakening of the plaque cap. To determine whether genotype-phenotype associations differed in different categories of acute coronary syndrome, we enrolled 650 consecutive Taiwanese patients diagnosed with acute coronary syndrome. Genotypic analysis was done on DNA using polymerase chain reaction and direct sequencing on the 5 adenines (5A)/6 adenines (6A; -1,171 bp) polymorphism in the MMP-3 gene promoter region. The frequency of the 5A polymorphism was higher in patients with acute coronary syndrome, especially in those with ST-elevation myocardial infarction (p <0.01). The number of 5A allele polymorphisms was strongly associated with more complex coronary angiography (diffuse score for 5A/5A vs 5A/6A vs 6A/6A, 6.6 ± 1.2 vs 5.3 ± 1.3 vs 4.6 ± 1.1, all p values <0.05 in subgroup analysis) and higher plasma MMP-3 activity in this acute coronary syndrome cohort (MMP-3 level for 6A/6A vs 5A/6A vs 5A/5A, 21.0 ± 2.2 vs 23.3 ± 2.1 vs 27.9 ± 2.2 ng/ml, all p values <0.05 in subgroup analysis). Multiple logistic regression analysis showed that this polymorphism, in addition to hypertension, diabetes, and a history of smoking, was an independent risk factor (odds ratio 2.2, 95% confidence interval 1.1 to 4.3, p = 0.02) for the occurrence of acute coronary syndrome. Further, carriers of this polymorphism who smoked had a significantly increased (20-fold) risk of acute coronary syndrome compared with nonsmoking noncarriers. In conclusion, the MMP-3 5A/6A polymorphism is significantly associated with the occurrence of acute coronary syndrome, MMP-3 activity, and severity of coronary atherosclerosis. There is a synergistic effect between smoking and this genetic risk factor for acute coronary syndrome.

Original languageEnglish
Pages (from-to)1012-1017
Number of pages6
JournalAmerican Journal of Cardiology
Volume98
Issue number8
DOIs
Publication statusPublished - 2006 Oct 15

Fingerprint

Matrix Metalloproteinase 3
Genetic Association Studies
Adenine
Acute Coronary Syndrome
Smoking
DNA-Directed DNA Polymerase
Coronary Angiography
Genetic Promoter Regions
Extracellular Matrix
Coronary Artery Disease
Logistic Models
Alleles
Odds Ratio
Regression Analysis
Confidence Intervals

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

@article{f5da0ddbfe0245a69df9c4f5c93de048,
title = "Genotype-Phenotype Association of Matrix Metalloproteinase-3 Polymorphism and Its Synergistic Effect With Smoking on the Occurrence of Acute Coronary Syndrome",
abstract = "Matrix metalloproteinase-3 (MMP-3) degrades the extracellular matrix and may contribute to the weakening of the plaque cap. To determine whether genotype-phenotype associations differed in different categories of acute coronary syndrome, we enrolled 650 consecutive Taiwanese patients diagnosed with acute coronary syndrome. Genotypic analysis was done on DNA using polymerase chain reaction and direct sequencing on the 5 adenines (5A)/6 adenines (6A; -1,171 bp) polymorphism in the MMP-3 gene promoter region. The frequency of the 5A polymorphism was higher in patients with acute coronary syndrome, especially in those with ST-elevation myocardial infarction (p <0.01). The number of 5A allele polymorphisms was strongly associated with more complex coronary angiography (diffuse score for 5A/5A vs 5A/6A vs 6A/6A, 6.6 ± 1.2 vs 5.3 ± 1.3 vs 4.6 ± 1.1, all p values <0.05 in subgroup analysis) and higher plasma MMP-3 activity in this acute coronary syndrome cohort (MMP-3 level for 6A/6A vs 5A/6A vs 5A/5A, 21.0 ± 2.2 vs 23.3 ± 2.1 vs 27.9 ± 2.2 ng/ml, all p values <0.05 in subgroup analysis). Multiple logistic regression analysis showed that this polymorphism, in addition to hypertension, diabetes, and a history of smoking, was an independent risk factor (odds ratio 2.2, 95{\%} confidence interval 1.1 to 4.3, p = 0.02) for the occurrence of acute coronary syndrome. Further, carriers of this polymorphism who smoked had a significantly increased (20-fold) risk of acute coronary syndrome compared with nonsmoking noncarriers. In conclusion, the MMP-3 5A/6A polymorphism is significantly associated with the occurrence of acute coronary syndrome, MMP-3 activity, and severity of coronary atherosclerosis. There is a synergistic effect between smoking and this genetic risk factor for acute coronary syndrome.",
author = "Ping-Yen Liu and Yi-Heng Li and Shih-Hung Chan and Lin, {Li Jen} and Hua-Lin Wu and Shi, {Guey Yueh} and Chen, {Jyh Hong}",
year = "2006",
month = "10",
day = "15",
doi = "10.1016/j.amjcard.2006.05.017",
language = "English",
volume = "98",
pages = "1012--1017",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Genotype-Phenotype Association of Matrix Metalloproteinase-3 Polymorphism and Its Synergistic Effect With Smoking on the Occurrence of Acute Coronary Syndrome

AU - Liu, Ping-Yen

AU - Li, Yi-Heng

AU - Chan, Shih-Hung

AU - Lin, Li Jen

AU - Wu, Hua-Lin

AU - Shi, Guey Yueh

AU - Chen, Jyh Hong

PY - 2006/10/15

Y1 - 2006/10/15

N2 - Matrix metalloproteinase-3 (MMP-3) degrades the extracellular matrix and may contribute to the weakening of the plaque cap. To determine whether genotype-phenotype associations differed in different categories of acute coronary syndrome, we enrolled 650 consecutive Taiwanese patients diagnosed with acute coronary syndrome. Genotypic analysis was done on DNA using polymerase chain reaction and direct sequencing on the 5 adenines (5A)/6 adenines (6A; -1,171 bp) polymorphism in the MMP-3 gene promoter region. The frequency of the 5A polymorphism was higher in patients with acute coronary syndrome, especially in those with ST-elevation myocardial infarction (p <0.01). The number of 5A allele polymorphisms was strongly associated with more complex coronary angiography (diffuse score for 5A/5A vs 5A/6A vs 6A/6A, 6.6 ± 1.2 vs 5.3 ± 1.3 vs 4.6 ± 1.1, all p values <0.05 in subgroup analysis) and higher plasma MMP-3 activity in this acute coronary syndrome cohort (MMP-3 level for 6A/6A vs 5A/6A vs 5A/5A, 21.0 ± 2.2 vs 23.3 ± 2.1 vs 27.9 ± 2.2 ng/ml, all p values <0.05 in subgroup analysis). Multiple logistic regression analysis showed that this polymorphism, in addition to hypertension, diabetes, and a history of smoking, was an independent risk factor (odds ratio 2.2, 95% confidence interval 1.1 to 4.3, p = 0.02) for the occurrence of acute coronary syndrome. Further, carriers of this polymorphism who smoked had a significantly increased (20-fold) risk of acute coronary syndrome compared with nonsmoking noncarriers. In conclusion, the MMP-3 5A/6A polymorphism is significantly associated with the occurrence of acute coronary syndrome, MMP-3 activity, and severity of coronary atherosclerosis. There is a synergistic effect between smoking and this genetic risk factor for acute coronary syndrome.

AB - Matrix metalloproteinase-3 (MMP-3) degrades the extracellular matrix and may contribute to the weakening of the plaque cap. To determine whether genotype-phenotype associations differed in different categories of acute coronary syndrome, we enrolled 650 consecutive Taiwanese patients diagnosed with acute coronary syndrome. Genotypic analysis was done on DNA using polymerase chain reaction and direct sequencing on the 5 adenines (5A)/6 adenines (6A; -1,171 bp) polymorphism in the MMP-3 gene promoter region. The frequency of the 5A polymorphism was higher in patients with acute coronary syndrome, especially in those with ST-elevation myocardial infarction (p <0.01). The number of 5A allele polymorphisms was strongly associated with more complex coronary angiography (diffuse score for 5A/5A vs 5A/6A vs 6A/6A, 6.6 ± 1.2 vs 5.3 ± 1.3 vs 4.6 ± 1.1, all p values <0.05 in subgroup analysis) and higher plasma MMP-3 activity in this acute coronary syndrome cohort (MMP-3 level for 6A/6A vs 5A/6A vs 5A/5A, 21.0 ± 2.2 vs 23.3 ± 2.1 vs 27.9 ± 2.2 ng/ml, all p values <0.05 in subgroup analysis). Multiple logistic regression analysis showed that this polymorphism, in addition to hypertension, diabetes, and a history of smoking, was an independent risk factor (odds ratio 2.2, 95% confidence interval 1.1 to 4.3, p = 0.02) for the occurrence of acute coronary syndrome. Further, carriers of this polymorphism who smoked had a significantly increased (20-fold) risk of acute coronary syndrome compared with nonsmoking noncarriers. In conclusion, the MMP-3 5A/6A polymorphism is significantly associated with the occurrence of acute coronary syndrome, MMP-3 activity, and severity of coronary atherosclerosis. There is a synergistic effect between smoking and this genetic risk factor for acute coronary syndrome.

UR - http://www.scopus.com/inward/record.url?scp=33749240721&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749240721&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2006.05.017

DO - 10.1016/j.amjcard.2006.05.017

M3 - Article

C2 - 17027562

AN - SCOPUS:33749240721

VL - 98

SP - 1012

EP - 1017

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 8

ER -